Trial Profile
Effects of Fimasartan on Insulin Secretion, and Interaction With DPP4 Inhibitors in Patients With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fimasartan (Primary) ; Amlodipine
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms Fimasartan study
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 27 Apr 2017 Status changed from active, no longer recruiting to completed.
- 14 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Dec 2016.